In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...

However, its specific role in gastric adenocarcinoma—the most common form of stomach cancer—remains unclear, with inconsistent findings across studies. To address this uncertainty, researchers ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...

Gastric cancer is often diagnosed in the advanced ... designation to zolbetuximab for the treatment of gastric and GEJ adenocarcinoma. Other companies developing claudin 18.2-targeted therapies ...

Increase seen across age groups, while incidence of colorectal adenocarcinoma increased most in those aged 15 to 34 years.

HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in gastric cancer ...

Scientists at Boston Medical Center have discovered a surprising connection between gallstones and a deadly type of cancer ...

"He said, 'I don't know how to tell you this, but you have stomach cancer,"’ Tiano, now 58, tells Yahoo Canada. She was diagnosed with stage 2 adenocarcinoma, a solid tumour that had grown from an ...

Investigators from Canada and the UK conducted a systematic review and meta-analysis to update evidence associating eradication of Helicobacter pylori with reduced gastric cancer risk.

A Multicenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid Tumors. Clin Cancer Res.